Does TELMISARTAN Cause Therapeutic product effect incomplete? 104 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 104 reports of Therapeutic product effect incomplete have been filed in association with TELMISARTAN (telmisartan). This represents 1.8% of all adverse event reports for TELMISARTAN.
104
Reports of Therapeutic product effect incomplete with TELMISARTAN
1.8%
of all TELMISARTAN reports
19
Deaths
32
Hospitalizations
How Dangerous Is Therapeutic product effect incomplete From TELMISARTAN?
Of the 104 reports, 19 (18.3%) resulted in death, 32 (30.8%) required hospitalization, and 18 (17.3%) were considered life-threatening.
Is Therapeutic product effect incomplete Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 104 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Therapeutic product effect incomplete?
ALBUTEROL (8,496)
ADALIMUMAB (6,986)
PREDNISONE (6,709)
METHOTREXATE (6,037)
TOFACITINIB (4,914)
SECUKINUMAB (4,661)
BUDESONIDE\FORMOTEROL (4,392)
TIOTROPIUM (4,327)
MEPOLIZUMAB (4,106)
ETANERCEPT (3,961)
Which TELMISARTAN Alternatives Have Lower Therapeutic product effect incomplete Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS